84
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comparison of the value of Mini-Cog and MMSE screening in the rapid identification of Chinese outpatients with mild cognitive impairment

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patients with mild cognitive impairment (MCI) are at high risk of dementia, but early identification and active intervention can reduce its morbidity and the incidence of dementia. There is currently no suitable neuropsychological assessment scale to effectively identify MCI in neurological outpatient departments in China. The Mini-Mental State Examination (MMSE) is often used to screen for MCI in outpatient departments in China.

          To compare the value of Mini-Cog and MMSE in screening patients for MCI in a neurological outpatient department, and determine differences in the value of Mini-Cog for different ages and educational levels.

          This was a retrospective study of 229 patients with suspected MCI who visited the Cangzhou Central Hospital between March 2012 and April 2016. The MCI group included 119 patients diagnosed with MCI and 110 cases without MCI (non-MCI group). The MCI patients were subgrouped as 40 to 60 years of age, 61 to 80 years, and >80 years; and as without education, ≤6 years education, and >6 years education. All subjects were assessed using the Mini-Cog and MMSE.

          There were significant differences in Mini-Cog ( P < .05) and MMSE ( P < .05) between the MCI and non-MCI groups. The sensitivity, specificity, positive predictive value, negative predictive value, and Youden index (85.71%, 79.41%, 0.8108, 0.8438, and 0.6550) of Mini-Cog were all higher than those of MMSE (64.76%, 71.57%, 0.7010, 0.6364, and 0.3370) in identifying MCI, but there was no significant difference in specificity ( P > .05). Mini-Cog was better than MMSE ( P < .05) for MCI patients with different ages and education levels.

          These results showed that the Mini-Cog was superior to MMSE in identifying MCI patients. Mini-Cog was less affected by age and education level than MMSE. The Mini-Cog assessment was short (3–4 minutes) and easily accepted by the patients. Mini-Cog could be more suitable for application in outpatient department in primary hospitals.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          The diagnosis and management of mild cognitive impairment: a clinical review.

          Cognitive decline is a common and feared aspect of aging. Mild cognitive impairment (MCI) is defined as the symptomatic predementia stage on the continuum of cognitive decline, characterized by objective impairment in cognition that is not severe enough to require help with usual activities of daily living.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Vitamin E and donepezil for the treatment of mild cognitive impairment.

            Mild cognitive impairment is a transitional state between the cognitive changes of normal aging and early Alzheimer's disease. In a double-blind study, we evaluated subjects with the amnestic subtype of mild cognitive impairment. Subjects were randomly assigned to receive 2000 IU of vitamin E daily, 10 mg of donepezil daily, or placebo for three years. The primary outcome was clinically possible or probable Alzheimer's disease; secondary outcomes were cognition and function. A total of 769 subjects were enrolled, and possible or probable Alzheimer's disease developed in 212. The overall rate of progression from mild cognitive impairment to Alzheimer's disease was 16 percent per year. As compared with the placebo group, there were no significant differences in the probability of progression to Alzheimer's disease in the vitamin E group (hazard ratio, 1.02; 95 percent confidence interval, 0.74 to 1.41; P=0.91) or the donepezil group (hazard ratio, 0.80; 95 percent confidence interval, 0.57 to 1.13; P=0.42) during the three years of treatment. Prespecified analyses of the treatment effects at 6-month intervals showed that as compared with the placebo group, the donepezil group had a reduced likelihood of progression to Alzheimer's disease during the first 12 months of the study (P=0.04), a finding supported by the secondary outcome measures. Among carriers of one or more apolipoprotein E epsilon4 alleles, the benefit of donepezil was evident throughout the three-year follow-up. There were no significant differences in the rate of progression to Alzheimer's disease between the vitamin E and placebo groups at any point, either among all patients or among apolipoprotein E epsilon4 carriers. Vitamin E had no benefit in patients with mild cognitive impairment. Although donepezil therapy was associated with a lower rate of progression to Alzheimer's disease during the first 12 months of treatment, the rate of progression to Alzheimer's disease after three years was not lower among patients treated with donepezil than among those given placebo. Copyright 2005 Massachusetts Medical Society.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Clock-drawing: is it the ideal cognitive screening test?

              The clock-drawing test has achieved widespread clinical use in recent years as a cognitive screening instrument and a significant amount of literature relates to its psychometric properties and clinical utility. This review aims to synthesize the available evidence and assess the value of this screening test according to well-defined criteria. A Medline and Psycho-info literature search of all languages was done from 1983 to 1998 including manual cross-referencing of bibliographies. A brief summary of all original scoring systems is provided as well as a review of replication studies. Psychometric data including correlations with other cognitive tests were recorded. Qualitative aspects of the test are also described. Among published studies, the mean sensitivity (85%) and specificity (85%) of the clock-drawing test are impressive. Correlations with the Mini-Mental State Examination and other cognitive tests was high, generally greater than r = 0.5. High levels of inter-rater and test-re-test reliability and positive predictive value are recorded and despite significant variability in the scoring systems, all report similar psychometric properties. The clock test also shows a sensitivity to cognitive change with good predictive validity. The clock-drawing test meets defined criteria for a cognitive screening instrument. It taps into a wide range of cognitive abilities including executive functions, is quick and easy to administer and score with excellent acceptability by subjects. Together with informant reports, the clock-drawing test is complementary to the widely used and validated Mini-Mental State Examination and should provide a significant advance in the early detection of dementia and in monitoring cognitive change. A simple scoring system with emphasis on the qualitative aspects of clock-drawing should maximize its utility. Copyright 2000 John Wiley & Sons, Ltd.
                Bookmark

                Author and article information

                Journal
                Medicine (Baltimore)
                Medicine (Baltimore)
                MEDI
                Medicine
                Wolters Kluwer Health
                0025-7974
                1536-5964
                June 2018
                01 June 2018
                : 97
                : 22
                : e10966
                Affiliations
                Department of Neurology, Cangzhou City Central Hospital, Cangzhou, China.
                Author notes
                []Correspondence: Xueyan Li, Department of Neurology, Cangzhou City Central Hospital, Cangzhou, China (e-mail: lxy18031792282@ 123456163.com ).
                Article
                MD-D-17-05673 10966
                10.1097/MD.0000000000010966
                6392520
                29851846
                4dcdb158-d3d4-480e-a5a8-f270eeb0a542
                Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc.

                This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

                History
                : 11 September 2017
                : 9 May 2018
                Categories
                5300
                Research Article
                Observational Study
                Custom metadata
                TRUE

                cognitive dysfunction,diagnostic tests and procedures,mini cognitive scale,mini-mental state examination

                Comments

                Comment on this article